HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Miriam Kim, MD

Hematologist Oncologist, Instructor of Medicine, Division of Oncology, Washington University School of Medicine

location_city Siteman Cancer Center

9 years treating AML

Clinical Expertise

Dr. Kim's goal is to develop chimeric antigen receptor T cells as a safe and effective therapy for AML. To this end, I am exploring different target antigens for CAR T cell therapy, investigating mechanisms to enhance the anti-tumor effect of CAR T cells, and finding methods to circumvent the toxicity associated with T cell immunotherapy in the setting of myeloid malignancies.


Siteman Cancer Center: 4921 Parkview Pl, St. Louis, MO 63110, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube